[144] Pegasystems Inc SEC Filing

Rhea-AI Filing Summary

Form 144 filed for Pegasystems Inc (PEGA) shows a proposed sale of 332 common shares through Morgan Stanley Smith Barney with an approximate aggregate market value of $19,132.06, and an approximate sale date of 09/08/2025. The shares were acquired on 09/05/2025 as restricted stock vesting under a registered plan and payment is recorded as 09/05/2025. The filer, Efsthathios A Kouninis, reported prior disposals in the past three months of 235 shares on 09/05/2025 (gross proceeds $12,925.00) and 582 shares on 07/28/2025 (gross proceeds $34,966.30). The filing notes 171,080,665 shares outstanding for the issuer and includes the standard insider representation regarding material nonpublic information.

Positive

• Regulatory compliance: Form 144 provides required disclosure under Rule 144 including broker, acquisition method, and attestation
• Transparency on acquisition: Shares were acquired via restricted stock vesting and dates are specified
• Small economic impact: Disclosed amounts are modest relative to 171,080,665 shares outstanding

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider sale size is immaterial to company capitalization and reflects routine disposition of vested restricted shares.

The filing discloses a small planned sale of 332 shares valued at $19,132.06 and prior recent sales totaling 817 shares generating modest proceeds. Against the reported 171,080,665 shares outstanding, these transactions represent a de minimis portion of equity and are unlikely to affect valuation or market dynamics. The filing documents acquisition via restricted stock vesting, which is a common liquidity event for insiders.

Corporate Governance Expert

TL;DR: Disclosure and timing comply with Rule 144 requirements; standard insider attestation included.

The notice properly lists broker, acquisition details (restricted stock vesting), and recent sales, and contains the required attestation that the seller is not aware of undisclosed material information. From a governance standpoint, the form demonstrates procedural compliance and transparency around insider liquidity. The amounts disclosed are small and do not indicate a change in executive control or governance risk.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	332	19132.06	171080665	09/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/05/2025	Restricted stock vesting under a registered plan	Issuer			332	09/05/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
EFSTATHIOS A KOUNINIS 225 Wyman Street Waltham MA 02451	Common	09/05/2025	235	12925.00
EFSTATHIOS A KOUNINIS 225 Wyman Street Waltham MA 02451	Common	07/28/2025	582	34966.30

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the PEGA Form 144 filed by Efsthathios A Kouninis disclose?

The filing discloses a proposed sale of 332 common shares (approximate value $19,132.06) with an approximate sale date of 09/08/2025 and notes prior sales of 235 and 582 shares in the past three months.

How were the shares acquired according to the Form 144?

The 332 shares were acquired on 09/05/2025 through restricted stock vesting under a registered plan and payment is recorded as 09/05/2025.

Which broker is handling the proposed sale in the Form 144?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY.

What prior insider sales are reported in the Form 144?

The filer reported selling 582 shares on 07/28/2025 for $34,966.30 and 235 shares on 09/05/2025 for $12,925.00.

Does the Form 144 indicate the filer has undisclosed material information?

By signing, the filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.